| Issue Date | Title | Type | Author(s) |
| 2019 | Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation | Articulo | Czechowicz, A. (Agnieszka) ; Palchaudhuri, R. (Rahul); Scheck, A. (Amelia); Hu, Y. (Yu); Hoggatt, J. (Jonathan); Saez, B. (Borja); Pang, W.W. (Wendy W.); Mansour, M.K. (Michael K.); Tate, T.A. (Tiffany A.); Chan, Y.Y. (Yan Yi); Walck, E. (Emily); Wernig, G. (Gerlinde); Shizuru, J.A. (Judith A.); Winau, F. (Florian); Scadden, D.T (David T.); Rossi, D.J. (Derrick J.) |
| 2017 | Adeno-associated viral vectors serotype 8 for cell-specific delivery of therapeutic genes in the central nervous system | Articulo | Pignataro, D. (Diego); Sucunza, D. (Diego); Vanrell, L. (Lucía); Lopez-Franco, E. (Esperanza); Dopeso-Reyes, I.G. (Iria G.); Vales, A. (África); Hommel, M. (Mirja); Rico, A.J. (Alberto J.); Lanciego, J.L. (José Luis); González-Aseguinolaza, G. (Gloria) |
| 2009 | Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters | Articulo | Bortolanza, S. (Sergia); Buñuales, M. (María); Alzuguren, P. (Pilar); Lamas, O. (Óscar); Aldabe, R. (Rafael); Prieto, J. (Jesús); Hernandez-Alcoceba, R. (Rubén) |
| 2005 | An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells | Articulo | Bortolanza, S. (Sergia); Qian, C. (Cheng); Kramer, M.G. (María Gabriela); Gomar, C. (Celia); Prieto, J. (Jesús); Farinati, F. (F.); Hernandez-Alcoceba, R. (Rubén) |
| 2007 | Human adenovirus replicates in immunocompetent models of pancreatic cancer in syrian hamsters | Articulo | Bortolanza, S. (Sergia); Alzuguren, P. (Pilar); Buñuales, M. (María); Qian, C. (Cheng); Prieto, J. (Jesús); Hernandez-Alcoceba, R. (Rubén) |
| 2006 | Gene therapy of liver cancer | Articulo | Hernandez-Alcoceba, R. (Rubén); Sangro, B. (Bruno); Prieto, J. (Jesús) |
| 2004 | Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer | Articulo | Wang, L. (Lin); Hernandez-Alcoceba, R. (Rubén); Shankar, V. (Vijay); Zabala, M. (Maider); Kochanek, S. (Stefan); Sangro, B. (Bruno); Kramer, M.G. (María Gabriela); Prieto, J. (Jesús); Qian, C. (Cheng) |
| 2008 | Interleukin-12 inhibits liver-specific drug-inducible systems in vivo | Articulo | Reboredo, M. (Mercedes); Zabala, M. (Maider); Mauleon, I. (Itsaso); Rivas, J. (Javier) de las; Kreppel, F. (Florian); Kochanek, S. (Stefan); Prieto, J. (Jesús); Hernandez-Alcoceba, R. (Rubén); Kramer, M.G. (María Gabriela) |
| 2010 | Design of virotherapy for effective tumor treatment | Articulo | Garcia-Aragoncillo, E. (Eva); Hernandez-Alcoceba, R. (Rubén) |
| 2011 | Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice | Articulo | Gonzalez-Aparicio, M. (Manuela); Alzuguren, P. (Pilar); Mauleon, I. (Itsaso); Medina-Echeverz, J. (José); Hervas-Stubbs, S. (Sandra); Mancheño, U. (Uxua); Berraondo, P. (Pedro); Crettaz, J. (Julien); González-Aseguinolaza, G. (Gloria); Prieto, J. (Jesús); Hernandez-Alcoceba, R. (Rubén) |
